文献速递消化系统肿瘤

MACROD2单倍剂量不足抑制PARP1活性并促进染色体不稳定和肠道肿瘤生长

MACROD2 Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal Tumors.
PubMed 文献 · Cancer Discov · 2018-06-07

该研究揭示人结直肠癌中MACROD2单ADP-核糖水解酶位点频繁缺失(约30%),以基因剂量依赖方式损害PARP1转移酶活性。MACROD2单倍剂量不足改变DNA修复和DNA损伤敏感性,导致染色体不稳定,并在ApcMin/+小鼠和异种移植中增强肠道肿瘤发生和生长。MACROD2缺失与散发性结直肠癌染色体不稳定程度相关,独立于临床参数和其他已知遗传驱动因素。

要点

  • MACROD2在结直肠癌中频繁缺失(约30%),单倍剂量不足即促进肿瘤。
  • MACROD2缺失抑制PARP1活性,损害DNA修复,导致染色体不稳定。
  • MACROD2缺失与散发性结直肠癌染色体不稳定程度相关,独立于已知驱动因素。

核心结论

  • MACROD2作为单倍剂量不足的肿瘤 suppressor,其功能缺失促进染色体不稳定,驱动癌症进化。

研究设计与样本

  • 研究通过人结直肠癌样本分析、细胞实验、ApcMin/+小鼠模型和异种移植实验,探究MACROD2缺失对PARP1活性和肿瘤生长的影响。

主要发现

  • 人结直肠癌中MACROD2位点频繁缺失(约30%),以基因剂量依赖方式损害PARP1转移酶活性。
  • MACROD2单倍剂量不足改变DNA修复和DNA损伤敏感性,导致染色体不稳定。
  • Macrod2杂合和纯合缺失增强ApcMin/+小鼠肠道肿瘤发生和人结直肠癌异种移植瘤生长。
  • 散发性结直肠癌中MACROD2缺失与染色体不稳定程度相关,独立于临床参数和其他已知遗传驱动因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ADP-ribosylation is an important posttranslational protein modification that regulates diverse biological processes, controlled by dedicated transferases and hydrolases. Here, we show that frequent deletions (∼30%) of the MACROD2 mono-ADP-ribosylhydrolase locus in human colorectal cancer cause impaired PARP1 transferase activity in a gene dosage-dependent manner. MACROD2 haploinsufficiency alters DNA repair and sensitivity to DNA damage and results in chromosome instability. Heterozygous and homozygous depletion of Macrod2 enhances intestinal tumorigenesis in ApcMin/+ mice and the growth of human colorectal cancer xenografts. MACROD2 deletion in sporadic colorectal cancer is associated with the extent of chromosome instability, independent of clinical parameters and other known genetic drivers. We conclude that MACROD2 acts as a haploinsufficient tumor suppressor, with loss of function promoting chromosome instability, thereby driving cancer evolution.Significance: Chromosome instability (CIN) is a hallmark of cancer. We identify MACROD2 deletion as a cause of CIN in human colorectal cancer. MACROD2 loss causes repression of PARP1 activity, impairing DNA repair. MACROD2 haploinsufficiency promotes CIN and intestinal tumor growth. Our results reveal MACROD2 as a major caretaker tumor suppressor gene. Cancer Discov; 8(8); 988-1005. ©2018 AACR.See related commentary by Jin and Burkard, p. 921This article is highlighted in the In This Issue feature, p. 899.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Sakthianandeswaren A, Parsons MJ, Mouradov D, et al. MACROD2 Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal Tumors. Cancer Discov. 2018. PMID: 29880585. doi:10.1158/2159-8290.CD-17-0909

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。